Michael Doubek

7.5k total citations · 1 hit paper
169 papers, 2.3k citations indexed

About

Michael Doubek is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Doubek has authored 169 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Genetics, 58 papers in Hematology and 55 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Doubek's work include Chronic Lymphocytic Leukemia Research (82 papers), Lymphoma Diagnosis and Treatment (53 papers) and Immunodeficiency and Autoimmune Disorders (28 papers). Michael Doubek is often cited by papers focused on Chronic Lymphocytic Leukemia Research (82 papers), Lymphoma Diagnosis and Treatment (53 papers) and Immunodeficiency and Autoimmune Disorders (28 papers). Michael Doubek collaborates with scholars based in Czechia, Germany and France. Michael Doubek's co-authors include Jiřı́ Mayer, Yvona Brychtová, Šárka Pospı́šilová, Martin Trbušek, Boris Tichý, Karla Plevová, Jitka Malčíková, Marek Mráz, Šárka Pavlová and Jana Kotašková and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Doubek

155 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of ALL in adults: 2024 ELN recommendations from a European expert panel

2024 45 citations Nicola Gökbuget, Nicolas Boissel et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Doubek Czechia	23	984	702	676	612	519	169	2.3k
G.J. Ossenkoppele Netherlands	34	677 0.7×	1.6k 2.2×	812 1.2×	783 1.3×	1.1k 2.2×	84	3.3k
Anne Tierens Norway	29	659 0.7×	590 0.8×	914 1.4×	504 0.8×	778 1.5×	101	2.2k
Luca Maurillo Italy	30	1.1k 1.1×	2.0k 2.9×	549 0.8×	1.1k 1.8×	499 1.0×	134	3.3k
Georg Hopfinger Austria	22	984 1.0×	390 0.6×	987 1.5×	280 0.5×	533 1.0×	58	1.8k
Nicola Cascavilla Italy	27	758 0.8×	1.1k 1.6×	491 0.7×	510 0.8×	517 1.0×	114	2.1k
David Joske Australia	20	809 0.8×	906 1.3×	774 1.1×	741 1.2×	634 1.2×	45	2.6k
Kazimierz Kuliczkowski Poland	29	1.1k 1.1×	1.2k 1.7×	794 1.2×	1.1k 1.8×	1.2k 2.4×	202	3.5k
Roberto Cairoli Italy	22	725 0.7×	1.1k 1.5×	446 0.7×	703 1.1×	302 0.6×	130	2.1k
Hyeoung‐Joon Kim South Korea	29	524 0.5×	1.4k 2.0×	436 0.6×	1.0k 1.7×	909 1.8×	213	3.0k
Koiti Inokuchi Japan	28	687 0.7×	1.2k 1.7×	302 0.4×	740 1.2×	525 1.0×	145	2.2k

Countries citing papers authored by Michael Doubek

Since Specialization

Citations

This map shows the geographic impact of Michael Doubek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Doubek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Doubek more than expected).

Fields of papers citing papers by Michael Doubek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Doubek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Doubek. The network helps show where Michael Doubek may publish in the future.

Co-authorship network of co-authors of Michael Doubek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Doubek. A scholar is included among the top collaborators of Michael Doubek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Doubek. Michael Doubek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Šterclová, Martina, et al.. (2025). The necessity of geneticist and pulmonologist collaboration in the treatment of monogenic interstitial lung diseases in adults. Breathe. 21(3). 240255–240255.

Gurský, Ján, Petr Kašpárek, Alena Pecinová, et al.. (2025). Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation. Leukemia. 39(11). 2745–2757. 1 indexed citations

Gökbuget, Nicola, Nicolas Boissel, Sabina Chiaretti, et al.. (2024). Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood. 143(19). 1903–1930. 45 indexed citations breakdown →

Зак, Павел, et al.. (2024). Real‐world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL‐CLLEAR study. Hematological Oncology. 42(3). e3280–e3280.

Kozubík, Kateřina Staňo, et al.. (2023). Extensive, 3.8 Mb-Sized Deletion of 22q12 in a Patient with Bilateral Schwannoma, Intellectual Disability, Sensorineural Hearing Loss, and Epilepsy. Molecular Syndromology. 14(5). 439–448.

Skalnı́ková, Magdalena, Kateřina Staňo Kozubík, Lenka Radová, et al.. (2022). A GP1BA Variant in a Czech Family with Monoallelic Bernard-Soulier Syndrome. International Journal of Molecular Sciences. 23(2). 885–885. 3 indexed citations

Zerkalenkova, Elena, Michael Doubek, Ekaterina A. Komech, et al.. (2022). The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 23(3). 1756–1756.

Doubková, Martina, Eva Kriegová, Simona Littnerová, et al.. (2021). DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study. Therapeutic Advances in Respiratory Disease. 15. 2663621857–2663621857. 11 indexed citations

Malčíková, Jitka, Šárka Pavlová, Lenka Radová, et al.. (2021). Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood. 138(25). 2670–2685. 24 indexed citations

10.

Navrkalová, Veronika, Karla Plevová, Karol Pál, et al.. (2021). LYmphoid NeXt-Generation Sequencing (LYNX) Panel. Journal of Molecular Diagnostics. 23(8). 959–974. 14 indexed citations

11.

Šterclová, Martina, Michael Doubek, & Martina Doubková. (2020). Familial pulmonary fibrosis - guidelines for diagnostics and treatment. Vnitřní lékařství. 66(6). 365–369. 1 indexed citations

12.

Doubková, Martina, Radoslav Matěj, Zita Chovancová, & Michael Doubek. (2020). Lung diseases and autoimmune hemolytic anemia associted with IgG4 disease. Vnitřní lékařství. 66(4). e22–e27. 2 indexed citations

13.

Delgado, Julio, Michael Doubek, Tycho Baumann, et al.. (2017). Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers ( IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI. American Journal of Hematology. 92(4). 375–380. 66 indexed citations

14.

Janovská, Pavlína, Karla Plevová, Markéta Kaucká, et al.. (2015). Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(2). 459–469. 52 indexed citations

15.

Kaucká, Markéta, Karla Plevová, Šárka Pavlová, et al.. (2013). The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration. Cancer Research. 73(5). 1491–1501. 82 indexed citations

16.

Brejcha, Martin, Yvona Brychtová, Karla Plevová, et al.. (2013). Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: A prospective analysis. Leukemia Research. 38(2). 170–175. 12 indexed citations

17.

Fiegl, Michael, Martin Erdel, Ingeborg Tinhofer, et al.. (2010). Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. Annals of Oncology. 21(12). 2410–2419. 22 indexed citations

18.

Doubek, Michael, Martin Brejcha, Zdeněk Pospı́šil, et al.. (2009). New prognostic markers of chronic lymphocytic leukemia in theeveryday hematological practice. A multicenter analysis.. 94.

19.

Doubek, Michael, Zdeněk Pospı́šil, Marek Borský, et al.. (2009). Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression. Experimental Hematology. 37(6). 659–672. 24 indexed citations

20.

Smetana, Karel, et al.. (2004). A Note on the Decreased Number and Loss of Fibrillar Centres in Nucleoli of Apoptotic HL-60 Leukaemic Granulocytic Precursors Produced by 5-Aminolaevulinic Acid-Based Photodynamic Treatment. Folia Biologica. 50(1). 15–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact